Credit Suisse’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Credit Suisse’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,743	Closed	-$145K	–	4527
2021 Q3	$145K	Buy	+1,743	New	+$153K	﹤0.01%	4284

Other funds holding HELP

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Perry Creek Capital New York $218M AUM 18.4% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ceeto Capital Group Coral Gables, Florida $369M AUM 34.8% 1-Year Est. Return

TCWP Beachwood, Ohio $40.8M AUM 31.25% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Credit Suisse's HELP Position: Q4 2021 in Review

Credit Suisse sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2021, closing a stake of 1,743 shares — an estimated $145K sold.

Credit Suisse first reported a position in HELP in Q3 2021 and held it in 1 quarter. The position peaked at $145K in Q3 2021. 65 funds tracked by Wall St. Rank hold HELP as of Q4 2021.

Credit Suisse reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Credit Suisse sold 1,743 Helus Pharma Inc. Common Stock shares in Q4 2021, an estimated $145K.
Credit Suisse first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and held it in 1 quarter.
Credit Suisse's Helus Pharma Inc. Common Stock position peaked at $145K in Q3 2021.
65 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2021.

Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.